Synthetic anti-cancer agents are developed through a rigorous process that includes:
Drug Discovery: Identifying potential anti-cancer compounds through high-throughput screening and computational methods. Preclinical Studies: Testing the compounds in cell cultures and animal models to evaluate their efficacy and safety. Clinical Trials: Conducting multiple phases of human trials to confirm safety and effectiveness. Regulatory Approval: Obtaining approval from regulatory bodies like the FDA for public use.
